Modulation of the GH/IGF-1 Axis and Reduction of Visceral Fat with Tesamorelin: Review of Clinical Trials and Metabolic Implications (2025)
Technical review of the effects of Tesamorelin on visceral fat reduction, GH/IGF-1 dynamics, and metabolic implications based on controlled clinical trials.
